Clinical Trial Update: Pomalidomide and Dexamethasone (PDex) in AL Amyloidosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pomalidomide with dexamethasone (PDex) for AL amyloidosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Al Amyloidosis

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Pomalyst (pomalidomide)

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Primary Amyloidosis of Light Chain Type | Phase 2 | Status: COMPLETED